Skip to main content

Table 1 Seroprevalence and IgG level of response

From: Optimization of a magnetic bead-based assay (MAGPIX®-Luminex) for immune surveillance of exposure to malaria using multiple Plasmodium antigens and sera from different endemic settings

Antigen Dielmo Ndiop Urban SM
IgG level Prevc (%) IgG levels Prev (%) IgG levels Prev (%)
MSP4-p20a 1103 64 2684 84 1315 69
[Range] [28–10,580] [42–13,160] [23–6381]
PfCSPa 262 52 536 57 187 47
[Range] [22–985] [22–4969] [18–1061]
PfAMA1a 282 52 402 49 456 58
[Range] [12–2352] [43–3065] [46–8930]
PmCSPa 691 56 537 62 79 19
[Range] [28–7365] [29–9278] [23–991]
MSP4-p20b 4.5 56 5.9 70 6.0 75
[Range] [1–14.7] [1–15.3] [1–12.9]
Schizont Agb 3.5 64 3.1 76 2.2 36
[Range] [1–9.3] [1–6.0] [1–7.4]
  1. a Levels and prevalence of Ab responses measured by MBA (expressed in MFI)
  2. b Levels and prevalence of Ab responses measured by ELISA (expressed in OD ratio)
  3. c Prev prevalence of responders